Anzeige
Mehr »
Lynx Broker
Login
Dienstag, 20.08.2019 Börsentäglich über 12.000 News von 606 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Zur alten Webversion

WKN: A140ML ISIN: JE00BYSS4X48 Ticker-Symbol: 038 
Tradegate
20.08.19
17:15 Uhr
86,08 Euro
+0,34
+0,40 %
1-Jahres-Chart
NOVOCURE LIMITED Chart 1 Jahr
5-Tage-Chart
NOVOCURE LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
84,42
84,78
20:10

Aktuelle News zur NOVOCURE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SoMarket cap of Israel-founded Novocure exceeds $9b7
FrCan NovoCure Hit $100?11
13.08.Novocure's Optune wins innovative medical device designation from China4
Börsennews zur NOVOCURE Aktie und weiteren Hot Stocks erhalten
10.08.NovoCure: Call Option Potential1
06.08.Novocure to Participate in Three Upcoming Investor Conferences36Novocure (NASDAQ: NVCR) announced today that it will participate in three upcoming investor conferences. Pritesh Shah, Novocure's Chief Commercial Officer, will participate in the Wedbush PacGrow...
► Artikel lesen
05.08.Why NovoCure Stock Soared 32% in July6
31.07.NovoCure: Good News On All Fronts9
30.07.NovoCure Ltd - S-8, Securities to be offered to employees in employee benefit plans1
26.07.NovoCure Stock Rises on Earnings Beat4
25.07.Why NovoCure Stock Is Surging Today7
25.07.NovoCure Nears Profitability as Revenue Continues to Soar4
25.07.Novocure's (NVCR) CEO Asaf Danziger on Q2 2019 Results - Earnings Call Transcript1
25.07.NovoCure Ltd - 10-Q, Quaterly Report1
25.07.NovoCure EPS beats by $0.06, beats on revenue8
25.07.NovoCure Ltd - 8-K, Current Report2
25.07.Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update9Quarterly net revenues of $86.7 million, representing 41 percent growth versus the second quarter 2018 The NovoTTF-100L System FDA approved to treat malignant pleural mesothelioma in combination...
► Artikel lesen
23.07.Can NovoCure's (NVCR) Steady Optune Business Aid Q2 Earnings?4
22.07.NovoCure Removes Overhang, Secures CMC Coverage For Newly-Diagnosed GBM-
22.07.Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference13The volume of Tumor Treating Fields presentations marks a record number of abstracts for Novocure at this conference Novocure (NASDAQ: NVCR) today announced 10 oral presentations and a special...
► Artikel lesen
18.07.NovoCure Ltd - 8-K, Current Report4
Seite:  Weiter >>
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2